Cabaletta Bio Inc (CABA) Stock Price, Quote & News

Company Profile

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases. Its lead product candidate is resecabtagene autoleucel, a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T, which is in Phase 1/2 clinical trials for the treatment of dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, juvenile myositis, lupus nephritis, non-renal systemic lupus erythe...

Industry: Biotechnology

Sector: Healthcare

Phone: 267 759 3100

Website: www.cabalettabio.com

Address:

2929 Arch Street, Suite 600, Philadelphia, United States

estatebuyersmia Dec. 24 at 6:24 PM

$CABA MERRY CHRISTMAS TO ALL THE BULLS AND SCREW THE BEARS...

0 · Reply

estatebuyersmia Dec. 24 at 5:41 PM

$CABA added 2.14, 2.15, 2.16.....

0 · Reply

Chrisf720 Dec. 24 at 5:31 PM

$CABA added @$2.13

0 · Reply

Bronco6970 Dec. 24 at 5:22 PM

$CABA added

0 · Reply

estatebuyersmia Dec. 24 at 5:21 PM

$CABA TAX LOSS SELLING ALMOST DONE.. SHARES HERE ARE A BARGAIN... ADD TO YOUR POSITION

0 · Reply

The1Ski Dec. 24 at 3:34 PM

$CABA Bottom?

1 · Reply

Bronco6970 Dec. 24 at 3:11 PM

$CABA adding here. January 2026 will be exceptional.

1 · Reply

Chartist0_0 Dec. 24 at 2:51 PM

$CABA the reason active boards on ST are so dangerous is posters encourage each other to just let their losses run. Risk management goes right out the window.

0 · Reply

GfromTn Dec. 24 at 2:47 PM

$CABA Merry Christmas everyone enjoy time with family and friends and celebrate the real reason for the season Jesus!! 2025 is almost in the books

1 · Reply

GfromTn Dec. 24 at 2:46 PM

$CABA retail sell off and stop loss raid giving shares to tutes!!! Don’t listen to any foolish sentiment here I would suggest you look at the percentage of large buys over the past month!! As retail gets weary the larger investors have scooped up those shares… prepare yourselves to be disappointed when you wake up and see this at 5-6 it will jump back up and violently

0 · Reply

Cabaletta Bio, Inc. (CABA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Nov 10, 2025, 7:30 AM EST - 6 weeks ago

Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 4, 2025, 8:00 AM EST - 7 weeks ago

Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December

Oct 27, 2025, 7:00 AM EDT - 2 months ago

Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025

Oct 14, 2025, 8:00 AM EDT - 2 months ago

Cabaletta Bio Announces Appointment of Steve Gavel as Chief Commercial Officer and Award of Inducement Grant

Oct 9, 2025, 12:00 PM EDT - 2 months ago

Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress

Oct 7, 2025, 6:20 AM EDT - 2 months ago

Cabaletta Bio: Still Optimistic, With News Being Guided To Be Shared Soon

Aug 27, 2025, 8:00 AM EDT - 4 months ago

Cabaletta Bio to Participate in Upcoming Investor Conferences in September

Aug 7, 2025, 7:30 AM EDT - 4 months ago

Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update

Jul 30, 2025, 11:07 AM EDT - 5 months ago

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

CAPR SRPT NGNE NTLA QURE RCKT

Jun 11, 2025, 9:54 AM EDT - 7 months ago

Cabaletta Bio Announces Pricing of Public Offering of Securities

Jun 11, 2025, 9:49 AM EDT - 7 months ago

Cabaletta Bio: Sector Headwinds And Funding Issues

Jun 11, 2025, 6:15 AM EDT - 7 months ago

Cabaletta Bio Announces Proposed Public Offering of Securities

Jun 11, 2025, 6:00 AM EDT - 7 months ago

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress

May 29, 2025, 8:00 AM EDT - 7 months ago

Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference

May 15, 2025, 7:00 AM EDT - 7 months ago

Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts

Mar 31, 2025, 7:00 AM EDT - 9 months ago

Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 19, 2025, 7:00 AM EDT - 10 months ago

Cellares and Cabaletta Bio Successfully Complete Manufacturing Technology Adoption Program for Rese-cel Using the Cell Shuttle™ Platform

Feb 26, 2025, 8:00 AM EST - 10 months ago

Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 18, 2025, 10:21 AM EST - 11 months ago

UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings

Feb 18, 2025, 7:00 AM EST - 11 months ago

Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings

Feb 11, 2025, 8:00 AM EST - 11 months ago

Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February

Jan 29, 2025, 8:00 AM EST - 11 months ago

Cabaletta Bio to Participate in Guggenheim's SMID Cap Biotech Conference

Jan 6, 2025, 2:28 PM EST - 1 year ago

Cabaletta Bio: Finding Optimism In Dire Straits

Oct 22, 2024, 11:41 AM EDT - 1 year ago

Cabaletta: Biotech With Large Potential, Interesting Bottom Pattern, Plenty Of Cash

Sep 25, 2024, 4:30 PM EDT - 1 year ago

Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024

Aug 8, 2024, 7:00 AM EDT - 1 year ago

Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update

Jul 2, 2024, 8:00 AM EDT - 1 year ago

Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum

Jun 28, 2024, 1:42 PM EDT - 1 year ago

Cabaletta Bio: Next Data Readout Needs To Be Mic Drop Moment

Jun 14, 2024, 2:00 AM EDT - 1 year ago

Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201

May 15, 2024, 7:00 AM EDT - 1 year ago

Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update

May 13, 2024, 8:00 AM EDT - 1 year ago

Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

Mar 21, 2024, 7:00 AM EDT - 1 year ago

Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Feb 27, 2024, 8:00 AM EST - 1 year ago

Cabaletta Bio to Participate in Upcoming Investor Conferences in March

Feb 1, 2024, 4:30 PM EST - 2 years ago

Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis

Jan 31, 2024, 8:00 AM EST - 2 years ago

Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Jan 31, 2024, 2:53 AM EST - 2 years ago

Cabaletta Bio: Two Differentiated CAR-T Platforms To Carry It Forward

Jan 2, 2024, 8:00 AM EST - 2 years ago

Cabaletta Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Dec 11, 2023, 5:58 AM EST - 2 years ago

Cabaletta Bio: Expanding The Success Of CAR-T Beyond Oncology

Dec 10, 2023, 2:44 AM EST - 2 years ago

Buy Cabaletta Bio's Promising SLE Treatment

Nov 28, 2023, 4:30 PM EST - 2 years ago

Cabaletta Bio to Participate in the 6th Annual Evercore ISI HealthCONx Conference

Nov 28, 2023, 3:55 PM EST - 2 years ago

Cabaletta Bio's and Gracell's stock falls sharply as FDA investigates risks of CAR-T therapy

Nov 9, 2023, 7:00 AM EST - 2 years ago

Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 6, 2023, 8:15 AM EST - 2 years ago

Cellares and Cabaletta Bio Partner to Evaluate Automated Manufacturing for CABA-201, Cabaletta's CD19-CAR T Cell Therapy on Cellares' Cell Shuttle Platform

Oct 30, 2023, 8:00 AM EDT - 2 years ago

Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in November

Sep 19, 2023, 4:56 AM EDT - 2 years ago

Cabaletta Bio: How Long Can Unique Cell Therapy Developer's Sensational Bull Run Continue?

Aug 30, 2023, 8:00 AM EDT - 2 years ago

Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September

Aug 10, 2023, 7:00 AM EDT - 2 years ago

Cabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business Update

Jul 24, 2023, 8:00 AM EDT - 2 years ago

Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors

May 31, 2023, 8:00 AM EDT - 2 years ago

Cabaletta Bio to Present at the Jefferies Healthcare Conference

estatebuyersmia Dec. 24 at 6:24 PM

$CABA MERRY CHRISTMAS TO ALL THE BULLS AND SCREW THE BEARS...

0 · Reply

estatebuyersmia Dec. 24 at 5:41 PM

$CABA added 2.14, 2.15, 2.16.....

0 · Reply

Chrisf720 Dec. 24 at 5:31 PM

$CABA added @$2.13

0 · Reply

Bronco6970 Dec. 24 at 5:22 PM

$CABA added

0 · Reply

estatebuyersmia Dec. 24 at 5:21 PM

$CABA TAX LOSS SELLING ALMOST DONE.. SHARES HERE ARE A BARGAIN... ADD TO YOUR POSITION

0 · Reply

The1Ski Dec. 24 at 3:34 PM

$CABA Bottom?

1 · Reply

Bronco6970 Dec. 24 at 3:11 PM

$CABA adding here. January 2026 will be exceptional.

1 · Reply

Chartist0_0 Dec. 24 at 2:51 PM

$CABA the reason active boards on ST are so dangerous is posters encourage each other to just let their losses run. Risk management goes right out the window.

0 · Reply

GfromTn Dec. 24 at 2:47 PM

$CABA Merry Christmas everyone enjoy time with family and friends and celebrate the real reason for the season Jesus!! 2025 is almost in the books

1 · Reply

GfromTn Dec. 24 at 2:46 PM

0 · Reply

Chartist0_0 Dec. 24 at 2:42 PM

$CABA Oh look, another "sale" on CABA.

1 · Reply

MiroslavBroz Dec. 24 at 2:39 PM

$CABA If it gets close to 2 I'll buy 20,000

0 · Reply

MiroslavBroz Dec. 24 at 2:23 PM

$CABA Christmas shopping today with a discount

0 · Reply

ChartistMoM Dec. 24 at 1:19 PM

$CABA It's my son. He's a grinch! He's been running around Walmart telling kids that Santa doesn't exist! What a moron.

0 · Reply

Chartist0_0 Dec. 24 at 12:14 PM

$CABA the shares have been gaslighting investors for weeks. Morning strength from retail buying gets met with bludgeoning by tutes.

0 · Reply

Majlo Dec. 24 at 8:38 AM

$CABA

0 · Reply

Moonman321 Dec. 24 at 7:07 AM

$CABA 😂 😂 😂

0 · Reply

WastedTrader Dec. 24 at 7:00 AM

$CABA smash the like

0 · Reply

WastedTrader Dec. 24 at 6:28 AM

$CABA still here, still holding, money inflow is higher than outflow, institutions are mass buying down the share price "accumulation" 🔥🚀

0 · Reply

MoneyGroupLLC Dec. 24 at 5:56 AM

Enter: $CABA Calls Strike Price: $2 Expiry Date: JAN 16 2026 Buy in Price: $0.15 - $0.16 Sell Price: $0.33 Profit : +118% (Turn every $1 into $2.18) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us

0 · Reply

Payster Dec. 23 at 9:20 PM

$CABA trying to run it after they took all your shares 👀

0 · Reply

Bullover00 Dec. 23 at 9:01 PM

$CABA Market maker closing It low of day....😂

1 · Reply

Market Cap	209.86M
Revenue (ttm)	0.00
Net Income (ttm)	-115.86M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	1,320,000
Avg Vol	3,492,870
Day's Range	N/A - N/A
Shares Out	96.27M
Stochastic %K	19%
Beta	3.17
Analysts	Strong Sell
Price Target	$14.12